APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lower Extremity Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lower Extremity Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173911900326 December 2025191 pages

Choose your research edition.

Industry ResearchLower Extremity Exoskeleton Enhancement Device Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Extremity Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Lower Extremity Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Extremity Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Lower Extremity Exoskeleton Enhancement Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lower Extremity Exoskeleton Enhancement Device include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lower Extremity Exoskeleton Enhancement Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lower Extremity Exoskeleton Enhancement Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lower Extremity Exoskeleton Enhancement Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lower Extremity Exoskeleton Enhancement Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Lower Extremity Exoskeleton Enhancement Device Segment by Company

Alter G

B-TEMIA Inc.

Cyberdyne

Ekso Bionics

Hocoma

Interactive Motion Technologies

LockHeed Martin

Myomo

Panasonic

Parker Hannifin

ReWalk Robotics

US Bionics

Pharos Medical Technology

Mile Bot

Shenzhen Ruihan Medical Technology

Siyi Intelligence

Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type

Conventional Type

Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment

Industrial

Others

Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lower Extremity Exoskeleton Enhancement Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lower Extremity Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lower Extremity Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lower Extremity Exoskeleton Enhancement Device Industry Trends Table 2. Lower Extremity Exoskeleton Enhancement Device Industry Drivers Table 3. Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 4. Lower Extremity Exoskeleton Enhancement Device Industry Restraints Table 5. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lower Extremity Exoskeleton Enhancement Device Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers Table 9. Global Lower Extremity Exoskeleton Enhancement Device Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lower Extremity Exoskeleton Enhancement Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers, Product Type & Application Table 13. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lower Extremity Exoskeleton Enhancement Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Smart Type Table 17. Major Manufacturers of Conventional Type Table 18. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 20. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 21. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2026) Table 22. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2027-2032) Table 23. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (Units) Table 25. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (Units) Table 26. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2026) Table 27. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Recovery Treatment Table 29. Major Manufacturers of Industrial Table 30. Major Manufacturers of Others Table 31. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 33. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 34. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2026) Table 35. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2027-2032) Table 36. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (Units) Table 38. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (Units) Table 39. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2026) Table 40. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2027-2032) Table 41. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 43. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 44. Global Lower Extremity Exoskeleton Enhancement Device Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Lower Extremity Exoskeleton Enhancement Device Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 48. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 49. Europe Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 51. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 58. Global Lower Extremity Exoskeleton Enhancement Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2026) Table 62. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2027-2032) Table 63. Alter G Company Information Table 64. Alter G Business Overview Table 65. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 67. Alter G Recent Development Table 68. B-TEMIA Inc. Company Information Table 69. B-TEMIA Inc. Business Overview Table 70. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 72. B-TEMIA Inc. Recent Development Table 73. Cyberdyne Company Information Table 74. Cyberdyne Business Overview Table 75. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 77. Cyberdyne Recent Development Table 78. Ekso Bionics Company Information Table 79. Ekso Bionics Business Overview Table 80. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 82. Ekso Bionics Recent Development Table 83. Hocoma Company Information Table 84. Hocoma Business Overview Table 85. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 87. Hocoma Recent Development Table 88. Interactive Motion Technologies Company Information Table 89. Interactive Motion Technologies Business Overview Table 90. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 92. Interactive Motion Technologies Recent Development Table 93. LockHeed Martin Company Information Table 94. LockHeed Martin Business Overview Table 95. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 97. LockHeed Martin Recent Development Table 98. Myomo Company Information Table 99. Myomo Business Overview Table 100. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 102. Myomo Recent Development Table 103. Panasonic Company Information Table 104. Panasonic Business Overview Table 105. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 107. Panasonic Recent Development Table 108. Parker Hannifin Company Information Table 109. Parker Hannifin Business Overview Table 110. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 112. Parker Hannifin Recent Development Table 113. ReWalk Robotics Company Information Table 114. ReWalk Robotics Business Overview Table 115. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 117. ReWalk Robotics Recent Development Table 118. US Bionics Company Information Table 119. US Bionics Business Overview Table 120. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 122. US Bionics Recent Development Table 123. Pharos Medical Technology Company Information Table 124. Pharos Medical Technology Business Overview Table 125. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 127. Pharos Medical Technology Recent Development Table 128. Mile Bot Company Information Table 129. Mile Bot Business Overview Table 130. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 132. Mile Bot Recent Development Table 133. Shenzhen Ruihan Medical Technology Company Information Table 134. Shenzhen Ruihan Medical Technology Business Overview Table 135. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 137. Shenzhen Ruihan Medical Technology Recent Development Table 138. Siyi Intelligence Company Information Table 139. Siyi Intelligence Business Overview Table 140. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 142. Siyi Intelligence Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Lower Extremity Exoskeleton Enhancement Device Distributors List Table 146. Lower Extremity Exoskeleton Enhancement Device Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Lower Extremity Exoskeleton Enhancement Device Product Image Figure 2. Global Lower Extremity Exoskeleton Enhancement Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Extremity Exoskeleton Enhancement Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Global Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Smart Type Image Figure 9. Conventional Type Image Figure 10. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032) Figure 13. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032) Figure 16. Recovery Treatment Image Figure 17. Industrial Image Figure 18. Others Image Figure 19. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032) Figure 22. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032) Figure 25. North America Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 27. U.S. Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 32. Germany Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 39. China Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 47. Brazil Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Lower Extremity Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Lower Extremity Exoskeleton Enhancement Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 58. North America Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 60. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Lower Extremity Exoskeleton Enhancement Device Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Lower Extremity Exoskeleton Enhancement Device Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Smart Type
  • Conventional Type
Applications
  • Recovery Treatment
  • Industrial
  • Others
Companies covered
  • Alter G
  • B-TEMIA Inc.
  • Cyberdyne
  • Ekso Bionics
  • Hocoma
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Panasonic
  • Parker Hannifin
  • ReWalk Robotics
  • US Bionics
  • Pharos Medical Technology
  • Mile Bot
  • Shenzhen Ruihan Medical Technology
  • Siyi Intelligence

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lower Extremity Exoskeleton Enhancement Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lower Extremity Exoskeleton Enhancement Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lower Extremity Exoskeleton Enhancement Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lower Extremity Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
3 Lower Extremity Exoskeleton Enhancement Device Market by Manufacturers
  1. 3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lower Extremity Exoskeleton Enhancement Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lower Extremity Exoskeleton Enhancement Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lower Extremity Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers, Product Type & Application
  7. 3.7 Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lower Extremity Exoskeleton Enhancement Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lower Extremity Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
4 Lower Extremity Exoskeleton Enhancement Device Market by Type
  1. 4.1 Lower Extremity Exoskeleton Enhancement Device Type Introduction
  2. 4.1.1 Smart Type
  3. 4.1.2 Conventional Type
  4. 4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type
  5. 4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  7. 4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
  8. 4.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type
  9. 4.3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  11. 4.3.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
5 Lower Extremity Exoskeleton Enhancement Device Market by Application
  1. 5.1 Lower Extremity Exoskeleton Enhancement Device Application Introduction
  2. 5.1.1 Recovery Treatment
  3. 5.1.2 Industrial
  4. 5.1.3 Others
  5. 5.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application
  6. 5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application
  10. 5.3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
6 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region
  1. 6.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2032)
  3. 6.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026)
  4. 6.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region
  1. 7.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region
  2. 7.1.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032)
  8. 7.2.2 North America Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032)
  11. 7.3.2 Europe Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alter G
  2. 8.1.1 Alter G Company Information
  3. 8.1.2 Alter G Business Overview
  4. 8.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  6. 8.1.5 Alter G Recent Developments
  7. 8.2 B-TEMIA Inc.
  8. 8.2.1 B-TEMIA Inc. Company Information
  9. 8.2.2 B-TEMIA Inc. Business Overview
  10. 8.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  12. 8.2.5 B-TEMIA Inc. Recent Developments
  13. 8.3 Cyberdyne
  14. 8.3.1 Cyberdyne Company Information
  15. 8.3.2 Cyberdyne Business Overview
  16. 8.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  18. 8.3.5 Cyberdyne Recent Developments
  19. 8.4 Ekso Bionics
  20. 8.4.1 Ekso Bionics Company Information
  21. 8.4.2 Ekso Bionics Business Overview
  22. 8.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  24. 8.4.5 Ekso Bionics Recent Developments
  25. 8.5 Hocoma
  26. 8.5.1 Hocoma Company Information
  27. 8.5.2 Hocoma Business Overview
  28. 8.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  30. 8.5.5 Hocoma Recent Developments
  31. 8.6 Interactive Motion Technologies
  32. 8.6.1 Interactive Motion Technologies Company Information
  33. 8.6.2 Interactive Motion Technologies Business Overview
  34. 8.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  36. 8.6.5 Interactive Motion Technologies Recent Developments
  37. 8.7 LockHeed Martin
  38. 8.7.1 LockHeed Martin Company Information
  39. 8.7.2 LockHeed Martin Business Overview
  40. 8.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  42. 8.7.5 LockHeed Martin Recent Developments
  43. 8.8 Myomo
  44. 8.8.1 Myomo Company Information
  45. 8.8.2 Myomo Business Overview
  46. 8.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  48. 8.8.5 Myomo Recent Developments
  49. 8.9 Panasonic
  50. 8.9.1 Panasonic Company Information
  51. 8.9.2 Panasonic Business Overview
  52. 8.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  54. 8.9.5 Panasonic Recent Developments
  55. 8.10 Parker Hannifin
  56. 8.10.1 Parker Hannifin Company Information
  57. 8.10.2 Parker Hannifin Business Overview
  58. 8.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  60. 8.10.5 Parker Hannifin Recent Developments
  61. 8.11 ReWalk Robotics
  62. 8.11.1 ReWalk Robotics Company Information
  63. 8.11.2 ReWalk Robotics Business Overview
  64. 8.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  66. 8.11.5 ReWalk Robotics Recent Developments
  67. 8.12 US Bionics
  68. 8.12.1 US Bionics Company Information
  69. 8.12.2 US Bionics Business Overview
  70. 8.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  72. 8.12.5 US Bionics Recent Developments
  73. 8.13 Pharos Medical Technology
  74. 8.13.1 Pharos Medical Technology Company Information
  75. 8.13.2 Pharos Medical Technology Business Overview
  76. 8.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  78. 8.13.5 Pharos Medical Technology Recent Developments
  79. 8.14 Mile Bot
  80. 8.14.1 Mile Bot Company Information
  81. 8.14.2 Mile Bot Business Overview
  82. 8.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  84. 8.14.5 Mile Bot Recent Developments
  85. 8.15 Shenzhen Ruihan Medical Technology
  86. 8.15.1 Shenzhen Ruihan Medical Technology Company Information
  87. 8.15.2 Shenzhen Ruihan Medical Technology Business Overview
  88. 8.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  90. 8.15.5 Shenzhen Ruihan Medical Technology Recent Developments
  91. 8.16 Siyi Intelligence
  92. 8.16.1 Siyi Intelligence Company Information
  93. 8.16.2 Siyi Intelligence Business Overview
  94. 8.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  96. 8.16.5 Siyi Intelligence Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
  2. 9.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lower Extremity Exoskeleton Enhancement Device Production Mode & Process
  6. 9.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
  9. 9.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst